Hepatocellular carcinoma (HCC) is a unique cancer entity that can be noninvasively diagnosed using imaging modalities without pathologic confirmation. In 2018, several major guidelines for HCC were updated to include hepatobiliary contrast agent magnetic resonance imaging (HBA-MRI) and contrast-enhanced ultrasound (CEUS) as major imaging modalities for HCC diagnosis. HBA-MRI enables the achievement of high sensitivity in HCC detection using the hepatobiliary phase (HBP). CEUS is another imaging modality with real-time imaging capability, and it is reported to be useful as a second-line modality to increase sensitivity without losing specificity for HCC diagnosis. However, until now, there is an unsolved discrepancy among guidelines on whether to accept “HBP hypointensity” as a definite diagnostic criterion for HCC or include CEUS in the diagnostic algorithm for HCC diagnosis. Furthermore, there is variability in terminology and inconsistencies in the definition of imaging findings among guidelines; therefore, there is an unmet need for the development of a standardized lexicon. In this article, we review the performance and limitations of HBA-MRI and CEUS after guideline updates in 2018 and briefly introduce some future aspects of imaging-based HCC diagnosis.
Citations
Citations to this article as recorded by
Mapping Knowledge Landscapes and Emerging Trends in Contrast-Enhanced Ultrasound for Breast Cancer: A Bibliometric and Visualization Analysis Chujun Wang, Zhen Hu, Xia Li, Yan Ding, Chunquan Zhang Ultrasound in Medicine & Biology.2026; 52(2): 284. CrossRef
Stimuli-responsive nanomedicines for hepatic diseases: mechanism, design, recent advances, and clinical translation Leyi Wang, Xue Zhang, Yinggang Li, Min Zhao, Gang Xu, Zhenyu Duan, Qiyong Gong, Kui Luo Journal of Controlled Release.2026; 390: 114522. CrossRef
SPARC: A programmable molecular diagnostic platform based on a signal-triggered, self-supplied crRNA and tiered PER-transcription-CRISPR cascade for early detection of hepatocellular carcinoma Xinying Chang, Cong Han, Haishuo Ji, Zhe Zeng, Jingyi Yang, Qirui Liu, Chao Jia, Lili Zhao, Chunlei Zhou, Shujia Chen, Wolfgang Knoll, Jia Li, Zhenglu Wang, Liyun Zhang Analytica Chimica Acta.2026; 1394: 345209. CrossRef
Prognostic Value of 18F-FDG and 18F-FEC Uptake in Hepatocellular Carcinoma Using Contrast-Enhanced Integrated PET/MRI: Correlation with Histology and Survival Marzieh Nejabat, Lucian Beer, Theresa Servus, Ahmed Ba-Ssalamah, Peter Mazal, Lukas Nics, Marcus Hacker, Georgios Karanikas, Sazan Rasul Cancers.2026; 18(10): 1526. CrossRef
Non-invasive model for predicting future lung metastasis of hepatocellular carcinoma based on imaging heterogeneity analysis Han Wu, Yuxuan Yang, Yuan Chen, Zhenli Liao, Wei Zhao, Guanghui Luo, Kai Tang, Yurong Jiang, Qiyang Li, Ziyao Jia, Mengfan Pan, Wanli Huang, Sirui Fu, Chongyang Duan, Liang Chen Cancer Imaging.2026;[Epub] CrossRef
Value of dual-energy CT in assessing therapeutic response after TACE for hepatocellular carcinoma: A retrospective comparative study with conventional CT Ziying Sun, Shuhang Zhang, Shuwei Zhou, Roberto Iezzi, Yu Song, Shuang Li, Qianhui Gui, Yuqing Lu, Xunjun Chen, Tiejun Song, Yiwei Wang, Ke Chen, Shenghong Ju, Yuan-Cheng Wang European Journal of Radiology.2026; 203: 113002. CrossRef
Impact of Different Degrees of Liver Iron Concentration on MRI Feature Assessment and LI‐RADS v2018 Category Assignment for Hepatocellular Carcinoma Sue Cao, Jianwen Li, Xiaorui Su, Xin Gao, Quanxi Li, Jie Zhang, Ruomi Guo Journal of Magnetic Resonance Imaging.2026;[Epub] CrossRef
The Current Research Landscape on Integrating Artificial Intelligence with Ultrasound Imaging for Cancer Diagnosis: A Dual-Database Bibliometric Study Xiaolei Miao, Jinxu Wang, Halisa Paerhati, Anshi Wu, Minhao Zhang Current Medicinal Chemistry.2026; 33(15): 3037. CrossRef
Photo‐Generated 1O2 Triggers In Situ RNA Crosslinking for High‐Contrast Tumor MRI and Effective Tumor Suppression Ying Luo, Weizhong Ding, Ming Jia, Yi Wang, Zijian Guo, Yuncong Chen, Dajing Guo Angewandte Chemie International Edition.2026;[Epub] CrossRef
Artificial Intelligence-Assisted Contrast-Enhanced Ultrasound for Perfusion Evaluation: State-of-the-Art Review Tianmin Tang, Meijuan Ling, Junyi Xie, Fangwen Zhou, Shuanshuan Guo, Amer M. Johri, Jianhua Zhou Ultrasound in Medicine & Biology.2026; 52(11): 2335. CrossRef
Photo‐Generated 1O2 Triggers In Situ RNA Crosslinking for High‐Contrast Tumor MRI and Effective Tumor Suppression Ying Luo, Weizhong Ding, Ming Jia, Yi Wang, Zijian Guo, Yuncong Chen, Dajing Guo Angewandte Chemie.2026;[Epub] CrossRef
A preoperative nomogram with MR elastography in identifying cytokeratin 19 status of hepatocellular carcinoma Yanan Gu, Kaipu Jin, Shanshan Gao, Wei Sun, Minyan Yin, Jing Han, Yunfei Zhang, Xiaolin Wang, Mengsu Zeng, Ruofan Sheng British Journal of Radiology.2025; 98(1166): 210. CrossRef
Comparative evaluation of non-contrast MRI versus gadoxetic acid-enhanced abbreviated protocols in detecting colorectal liver metastases Haoran Dai, Cheng Yan, Xi Jia, Yuyao Xiao, Xinyue Liang, Chun Yang, Kai Liu, Mengsu Zeng Insights into Imaging.2025;[Epub] CrossRef
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer Yuqi Feng, Letian Fang, Guangwen Cao Hepatoma Research.2025;[Epub] CrossRef
Radiomics and Deep Learning as Important Techniques of Artificial Intelligence — Diagnosing Perspectives in Cytokeratin 19 Positive Hepatocellular Carcinoma Fei Wang, Chunyue Yan, Xinlan Huang, Jiqiang He, Ming Yang, Deqiang Xian Journal of Hepatocellular Carcinoma.2025; Volume 12: 1129. CrossRef
Application of high-frequency ultrasound in occult focal liver lesions: Does it help? Hong Qin, Zheng-biao Ji, Yu-li Zhu, Qian-nan Zhao, Kai Yuan, Dan Zuo, Xiao-long Zhang, Yi Dong, Wen-ping Wang Clinical Hemorheology and Microcirculation.2025; 90(2): 84. CrossRef
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment Stephen Lam Chan, Hui-Chuan Sun, Yang Xu, Hongmei Zeng, Hashem B El-Serag, Jeong Min Lee, Myron E Schwartz, Richard S Finn, Jinsil Seong, Xin Wei Wang, Valérie Paradis, Ghassan K Abou-Alfa, Lorenza Rimassa, Jia-Horng Kao, Bo-Heng Zhang, Josep M Llovet, Jo The Lancet.2025; 406(10504): 731. CrossRef
Dynamic contrast-enhanced ultrasound perfusion analysis for preoperative prediction of aggressive hepatocellular carcinoma subtypes Xin Guan, Xiao Li, Daohui Yang, Chongke Zhao, Dan Lu, Yaqin Zhang, Yikang Sun, Boyang Zhou, Zitong Chen, Xinyuan Hu, Hong Han, Qing Lu, Huixiong Xu, Lifan Wang Insights into Imaging.2025;[Epub] CrossRef
Integrated multi-task learning framework for hepatocellular carcinoma segmentation and histological grading using fused multi-phase MRI Zhihui You, Yuanru Wang, Shili Zhou Abdominal Radiology.2025; 51(5): 2439. CrossRef
Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI‐RADS Version 2018 and LI‐RADS Modifications Yanjin Qin, Jing Zhang, Danyang Xu, Xiaoqi Zhou, Zhoukun Ling, Lujie Li, Qiaochu Zhao, Zhi Dong, Jifei Wang, Hua‐Song Cai, Hongxiang Li, Lie‐Guang Zhang, Shi‐Ting Feng Liver International.2025;[Epub] CrossRef
Trends of liver cell carcinoma mortality in the United States by demographics and geography Sishir Doddi, Oscar Salichs, Taryn Hibshman, Puneet Bhargava Current Problems in Diagnostic Radiology.2024; 53(2): 208. CrossRef
Comparative Performance of 2018 LI‐RADS versus Modified LIRADS (mLI‐RADS): An Individual Participant Data Meta‐Analysis Stacy M. Goins, Hanyu Jiang, Christian B. van der Pol, Jean‐Paul Salameh, Eric Lam, Robert G. Adamo, Matthew D.F. McInnes, Andreu F. Costa, Christopher Clarke, Sang Hyun Choi, Tyler J. Fraum, Daniel R. Ludwig, Bin Song, Ijin Joo, Andrea S. Kierans, So Yeo Journal of Magnetic Resonance Imaging.2024; 60(3): 1082. CrossRef
Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria Hyo-Jin Kang, Jeong Min Lee, Jeong Hee Yoon, Jeongin Yoo, Jung Hoon Kim, Jiwon Park American Journal of Roentgenology.2024;[Epub] CrossRef
Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022 Yuri Cho, Bo Hyun Kim, Young-Suk Lim Digestive Disease Interventions.2024; 08(03): 169. CrossRef
Atypical Presentation of Hepatocellular Carcinoma in a Chronic Alcoholic: Diagnostic Challenges and Therapeutic Approach Bhagyasri Nunna, Pratapsingh Parihar, Suhit Naseri, Rishabh Dhabalia, Saraswathula Bharadwaj Cureus.2024;[Epub] CrossRef
Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging Jae Seok Bae, Jeong Min Lee, Bo Yun Hur, Jeongin Yoo, Sae-Jin Park Journal of Liver Cancer.2024; 24(2): 206. CrossRef
Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline Hyo-Jin Kang, Jeong Min Lee, Se Woo Kim Ultrasonography.2023; 42(4): 479. CrossRef
The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Journal of Gastroenterology and Hepatology.2023; 38(5): 716. CrossRef
Diagnostic efficacy of contrast-enhanced ultrasound, dynamic contrast-enhanced MRI combined with tumor markers AFP and DCP for primary hepatocellular carcinoma Xiaohai Guo, Changqing Tian, Gaili Liu, Xiufang Mi, Dezhen Gao Biotechnology and Genetic Engineering Reviews.2023; : 1. CrossRef
Clinical Encounters with Kupffer Cells While Managing Patients with Liver Diseases Vijay Alexander, Kovi Sai Lakshmi, C. E. Eapen Gastroenterology, Hepatology and Endoscopy Practice.2023; 3(2): 39. CrossRef
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi Clinical and Molecular Hepatology.2023; 29(2): 197. CrossRef
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao Clinical and Molecular Hepatology.2023; 29(2): 206. CrossRef
Development of a deep-learning model for classification of LI-RADS major features by using subtraction images of MRI: a preliminary study Junghoan Park, Jae Seok Bae, Jong-Min Kim, Joseph Nathanael Witanto, Sang Joon Park, Jeong Min Lee Abdominal Radiology.2023; 48(8): 2547. CrossRef
Ultrasound radiomics in the prediction of microvascular invasion in hepatocellular carcinoma: A systematic review and meta-analysis Qinyu Xiao, Wenjun Zhu, Huanliang Tang, Lijie Zhou Heliyon.2023; 9(6): e16997. CrossRef
Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation – Real-world data from the prospective multicentre DEGUM study Barbara Meitner-Schellhaas, Daniel Jesper, Rüdiger Stephan Goertz, Sebastian Zundler, Deike Strobel Clinical Hemorheology and Microcirculation.2023; 84(4): 413. CrossRef
Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods Seungchul Han, Se Woo Kim, Sungeun Park, Jeong Hee Yoon, Hyo-Jin Kang, Jeongin Yoo, Ijin Joo, Jae Seok Bae, Jeong Min Lee Ultrasound in Medicine & Biology.2023; 49(10): 2256. CrossRef
Suboptimal performance of LI-RADS v2018 on gadoxetic acid–enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates Na Eun Oh, Sang Hyun Choi, Sehee Kim, Habeen Lee, Hyeon Ji Jang, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin European Radiology.2023; 34(1): 465. CrossRef
Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings Sung Won Lee, Min Kyu Kang, Xiang Zhang Journal of Liver Cancer.2023; 23(2): 238. CrossRef
Does threshold growth benefit imaging criteria when used as a major diagnostic imaging feature for hepatocellular carcinoma? Ji Young Choi, Rohee Park, Sang Hyun Choi, Hyeon Ji Jang, Se Jin Choi, Subin Heo European Journal of Radiology.2023; 169: 111188. CrossRef
Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis Stacy M. Goins, Hanyu Jiang, Christian B. van der Pol, Jean-Paul Salameh, Eric Lam, Robert G. Adamo, Matthew D. F. McInnes, Andreu F. Costa, An Tang, Ayman S. Alhasan, Brian C. Allen, Caecilia S. Reiner, Christopher Clarke, Milena Cerny, Jin Wang, Sang Hy Radiology.2023;[Epub] CrossRef
First
Prev
